ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2,1,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
3,1,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
4,1,Erythema multiforme,Bullous conditions,Epidermal and dermal conditions,Skin,N
5,1,Ageusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
6,1,Thermal burn,Thermal burns,Injuries by physical agents,Inj&P,N
7,1,Parotid gland enlargement,Salivary gland enlargements,Salivary gland conditions,Gastr,N
8,1,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
8,2,Parotid duct obstruction,Salivary gland stenosis and obstruction,Salivary gland conditions,Gastr,N
9,1,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
9,2,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
9,3,Candida infection,Candida infections,Fungal infectious disorders,Infec,N
9,4,Fluid retention,Total fluid volume increased,Electrolyte and fluid balance conditions,Metab,N
9,5,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
9,6,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
9,7,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
9,8,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
10,1,Organ failure,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
11,1,Burns first degree,Thermal burns,Injuries by physical agents,Inj&P,N
11,2,Burns first degree,Thermal burns,Injuries by physical agents,Inj&P,N
11,3,Hyperaemia,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
11,4,Obstructive airways disorder,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
11,5,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
11,6,Stomatitis,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
11,7,Stridor,"Laryngeal spasm, oedema and obstruction",Upper respiratory tract disorders (excl infections),Resp,N
11,8,Vocal cord inflammation,Laryngeal and adjacent sites disorders NEC (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
12,1,Areflexia,Abnormal reflexes,Neurological disorders NEC,Nerv,N
12,2,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
12,3,Cerebral disorder,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
12,4,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
12,5,Death,Death and sudden death,Fatal outcomes,Genrl,Y
12,6,Hypertonia,Muscle tone abnormal,Neuromuscular disorders,Nerv,N
12,7,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
12,8,Miosis,Pupil disorders,Ocular neuromuscular disorders,Eye,N
12,9,Poisoning deliberate,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
12,10,Pulmonary oedema,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
12,11,Sinus bradycardia,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
12,12,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
13,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
13,2,Abdominal mass,Abdominal findings abnormal,Gastrointestinal signs and symptoms,Gastr,N
13,3,Ascites,Peritoneal and retroperitoneal disorders,Peritoneal and retroperitoneal conditions,Gastr,N
13,4,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
13,5,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
13,6,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
13,7,Drug abuse,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
13,8,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
13,9,Hepatomegaly,Hepatobiliary signs and symptoms,Hepatic and hepatobiliary disorders,Hepat,N
13,10,Incorrect route of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
13,11,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
13,12,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
13,13,Schizophrenia,Schizophrenia NEC,Schizophrenia and other psychotic disorders,Psych,N
13,14,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
14,1,Accidental exposure to product,Accidental exposures to product,Medication errors and other product use errors and issues,Inj&P,N
14,2,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
14,3,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
14,4,Chemical burn,Chemical injuries,"Exposures, chemical injuries and poisoning",Inj&P,N
14,5,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
14,6,Soft tissue injury,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
14,7,Soft tissue necrosis,Soft tissue disorders NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
15,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
15,2,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
15,3,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
15,4,Autoimmune disorder,Autoimmune disorders NEC,Autoimmune disorders,Immun,N
15,5,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
15,6,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
15,7,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
15,8,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
15,9,Food allergy,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
15,10,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
15,11,Hypophagia,Appetite disorders,Appetite and general nutritional disorders,Metab,N
15,12,Impaired quality of life,Social issues NEC,Lifestyle issues,SocCi,N
15,13,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
15,14,Movement disorder,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
15,15,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
15,16,Reaction to preservatives,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
15,17,Rib fracture,Thoracic cage fractures and dislocations,Bone and joint injuries,Inj&P,N
15,18,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
15,19,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
16,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
16,2,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
16,3,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
16,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
16,5,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
17,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
17,2,Exposure to toxic agent,Exposures to agents or circumstances NEC,"Exposures, chemical injuries and poisoning",Inj&P,N
17,3,Screaming,General signs and symptoms NEC,General system disorders NEC,Genrl,N
17,4,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
18,1,Chemical burn,Chemical injuries,"Exposures, chemical injuries and poisoning",Inj&P,N
18,2,Physical disability,Disability issues,Lifestyle issues,SocCi,N
19,1,Application site burn,Application site reactions,Administration site reactions,Genrl,N
19,2,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
19,3,Loss of personal independence in daily activities,Disability issues,Lifestyle issues,SocCi,N
20,1,Allergic reaction to excipient,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
20,2,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
20,3,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
20,4,Lacrimation increased,Lacrimation disorders,Eye disorders NEC,Eye,N
20,5,Rhinorrhoea,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
21,1,Application site inflammation,Application site reactions,Administration site reactions,Genrl,N
21,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
21,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
21,4,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
22,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
22,2,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
22,3,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
23,1,Chemical burn of skin,Chemical injuries,"Exposures, chemical injuries and poisoning",Inj&P,N
23,2,Product preparation error,Product preparation errors and issues,Medication errors and other product use errors and issues,Inj&P,N
23,3,Product use complaint,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
24,1,Blast injury,Atmospheric pressure injuries,Injuries by physical agents,Inj&P,N
24,2,Chemical burns of eye,Chemical injuries,"Exposures, chemical injuries and poisoning",Inj&P,N
24,3,Emotional distress,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
24,4,Loss of personal independence in daily activities,Disability issues,Lifestyle issues,SocCi,N
24,5,Product complaint,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
24,6,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
25,1,Exposure via ingestion,Pathways and sources of exposure,"Exposures, chemical injuries and poisoning",Inj&P,N
26,1,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
26,2,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
27,1,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
28,1,Exposure via ingestion,Pathways and sources of exposure,"Exposures, chemical injuries and poisoning",Inj&P,N
29,1,Ill-defined disorder,General signs and symptoms NEC,General system disorders NEC,Genrl,N
29,2,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
30,1,Exposure via ingestion,Pathways and sources of exposure,"Exposures, chemical injuries and poisoning",Inj&P,Y
31,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
31,2,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
32,1,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
32,2,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
33,1,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
33,2,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
34,1,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
34,2,Suicide attempt,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
35,1,Completed suicide,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,Y
35,2,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
36,1,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
36,2,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
37,1,Exposure via ingestion,Pathways and sources of exposure,"Exposures, chemical injuries and poisoning",Inj&P,N
37,2,Suicide attempt,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
38,1,Burns second degree,Thermal burns,Injuries by physical agents,Inj&P,N
39,1,Accidental exposure to product,Accidental exposures to product,Medication errors and other product use errors and issues,Inj&P,N
39,2,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
39,3,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
40,1,Adverse event,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
40,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
41,1,Product preparation error,Product preparation errors and issues,Medication errors and other product use errors and issues,Inj&P,N
41,2,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
42,1,Product solubility abnormal,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
42,2,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
43,1,Exposure to toxic agent,Exposures to agents or circumstances NEC,"Exposures, chemical injuries and poisoning",Inj&P,N
43,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
43,3,Skin disorder,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
44,1,Allergic cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
44,2,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
44,3,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
44,4,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
44,5,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
44,6,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
45,1,Accidental exposure to product by child,Accidental exposures to product,Medication errors and other product use errors and issues,Inj&P,N
45,2,Crying,General signs and symptoms NEC,General system disorders NEC,Genrl,N
45,3,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
45,4,Product closure issue,Product packaging issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
45,5,Scar,Skin injuries NEC,Injuries NEC,Inj&P,N
46,1,Chemical burn,Chemical injuries,"Exposures, chemical injuries and poisoning",Inj&P,N
46,2,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
46,3,Expired product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
46,4,Product preparation error,Product preparation errors and issues,Medication errors and other product use errors and issues,Inj&P,N
46,5,Sensitive skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
46,6,Skin hyperpigmentation,Hyperpigmentation disorders,Pigmentation disorders,Skin,N
47,1,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
48,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
48,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
48,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
48,4,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
49,1,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
49,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
49,3,Productive cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
50,1,Chemical burn of skin,Chemical injuries,"Exposures, chemical injuries and poisoning",Inj&P,N
50,2,Product use complaint,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
51,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
51,2,Death,Death and sudden death,Fatal outcomes,Genrl,Y
51,3,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
51,4,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
51,5,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
51,6,Skin ulcer,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
52,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
52,2,Product preparation issue,Product preparation errors and issues,Medication errors and other product use errors and issues,Inj&P,N
53,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
53,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
53,3,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
53,4,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
53,5,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
53,6,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
53,7,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
53,8,Wound secretion,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
54,1,Therapeutic response unexpected,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
55,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
55,2,Product preparation error,Product preparation errors and issues,Medication errors and other product use errors and issues,Inj&P,N
55,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
55,4,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
56,1,Application site burn,Application site reactions,Administration site reactions,Genrl,N
56,2,Application site pain,Application site reactions,Administration site reactions,Genrl,N
56,3,Loss of personal independence in daily activities,Disability issues,Lifestyle issues,SocCi,N
56,4,Product use complaint,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
56,5,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
56,6,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
57,1,Skin injury,Skin injuries NEC,Injuries NEC,Inj&P,N
58,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
58,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
58,3,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
59,1,Product preparation error,Product preparation errors and issues,Medication errors and other product use errors and issues,Inj&P,N
59,2,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
